News

  • Associate Professor Graeme Polglase, Research Group Head, Perinatal Transition Research Group at Hudson Institute of Medical Research

    Newborn delayed cord clamping recommendations

    Premature and full-term babies who do not require respiratory support may benefit from leaving their umbilical cord unclamped for at least 60 seconds after birth, according to the authors of a Perspective published by the Medical Journal of Australia.…  Read more

  • Flicking the immune ‘switch’ to repair multiple sclerosis damage

    Discovering new treatments to repair damage to nerve cells caused by Multiple Sclerosis (MS) will be the focus of research at Hudson Institute of Medical Research, thanks to funding from MS Research Australia. Dr Claire McCoy has been awarded a $25,000 MS Research Australia incubator grant to progress her research into the role of macrophages,…  Read more

  • Leading next generation IVF

    La Trobe University and Hudson Institute of Medical Research are leading pioneering research aimed at understanding infertility and improving the rate of assisted and natural pregnancies – an approach that may lead to ‘personalised IVF’. The team, led by Dr David Greening from La Trobe Institute for Molecular Science and Professor Lois Salamonsen from Hudson…  Read more

  • Childhood cancer ‘organoid’ program set to revolutionise treatment

    The Hudson Monash Precision Medicine Program hopes to significantly improve treatment for childhood cancer patients with the greatest unmet clinical need – those diagnosed with brain cancers and solid tumours. Launched today (February 7) ahead of International Childhood Cancer Day on February 15, the two year program is being established with a $1.3 million investment…  Read more

  • Dr Jason Cain from the Developmental and Cancer Biology Research Group at Hudson Institute

    VCA Fellowship targets ‘rare and aggressive’ childhood cancer

    Dr Jason Cain has been awarded a Victorian Cancer Agency (VCA) Mid-Career Fellowship for his research to help tackle a rare and aggressive form of childhood cancer. Dr Cain was one of 14 successful VCA funding recipients announced by Acting Minister for Health, Martin Foley as part of a $7 million investment by the Victorian…  Read more

  • Associate Professor Ron Firestein from the Cancer Genetics and Functional Genomics Research Group at Hudson Institute

    Cutting edge genome editing toolbox for precision medicine

    A cutting-edge CRISPR library containing more than 36,000 molecular scissors targeting every known gene in the human genome is realising the clinical potential of precision medicine research at Hudson Institute. Hudson Institute scientists now have access to the award-winning Merck/Sanger Arrayed Whole Genome CRISPR Library on-site at the Monash Health Translation Precinct. Associate Professor Ron…  Read more

  • Professor Rosemary Horne awarded Doctor of Science

    Professor Rosemary Horne has been awarded a Doctor of Science from Monash University for more than three decades of research that has shaped the understanding of sleep in children and infants. The Doctor of Science (DSc) is of a higher standing than a PhD and is awarded for work that makes an original, substantial and…  Read more

  • Dr Joohyung Lee, Honorary Research Associate, working at the lab bench and using a microscope to assist with his medical research

    Therapy brings long-term hope for halting Parkinson’s Disease

    How deep brain stimulation therapy could help to slow or halt the progression of Parkinson’s Disease is the focus of new research by Dr Joohyung Lee, thanks to a grant from the Bethlehem Griffiths Research Foundation. “Parkinson’s disease (PD) is primarily associated with the inability to initiate and control voluntary movement. These symptoms result from…  Read more

  • Dr Jun Yang from the Cardiovascular Endocrinology Research Group at Hudson Institute

    Simple blood test could decrease risk of stroke, heart attack

    Australia’s largest study of a common yet underdiagnosed cause of high blood pressure is starting at Hudson Institute, with the aim of preventing heart attack and stroke. Primary aldosteronism (PA) is a potentially curable cause of high blood pressure (hypertension) caused by the over-production of the hormone aldosterone from the adrenal glands. If left undiagnosed,…  Read more

  • Hudson Institute joins international paediatric cancer consortium

    Hudson Institute scientists will share expertise with leading international research institutions to progress research and improve treatments for children and adolescents with brain cancer. Hudson Institute has been announced as the first Australian member of the US-based Children’s Brain Tumor Tissue Consortium (CBTTC) and joins a collaborative, multi-institutional research program dedicated to the study and…  Read more

Hudson News

Get the inside view on discoveries and patient stories

Stay connected